Allspring Global Investments Holdings LLC Has $37.12 Million Stock Holdings in UFP Technologies, Inc. $UFPT
Allspring Global Investments Holdings LLC significantly increased its stake in UFP Technologies (NASDAQ: UFPT) by 60.3% in the fourth quarter of last year, bringing its holdings to 166,135 shares valued at approximately $37.12 million. Other institutional investors have also adjusted their positions in the company, which reported strong Q4 earnings, beating estimates with $2.44 EPS and revenue of $148.92 million. Analysts currently rate UFP Technologies as a "Hold" with an average target price of $289.00.
Dow Jones sells land in Chicopee, says no change to operations
Dow Jones & Co. sold a 19-acre vacant parcel of land in Chicopee to UFP Technologies for $40,000. The sale, which took place on March 18, 2026, involves land adjacent to both companies' existing facilities. Dow Jones stated that this transaction will not impact its current operations in Chicopee.
Precision Trading with Ufp Technologies Inc. (UFPT) Risk Zones
This article provides a precision trading analysis for Ufp Technologies Inc. (UFPT), identifying support and resistance levels and suggesting potential trading strategies. It highlights a strong risk-reward setup with a target gain of 16.1% versus a 0.3% risk. The analysis includes institutional trading strategies for different risk profiles and a multi-timeframe signal analysis.
UFP Technologies Inc (UFPT) Stock Price Quote Today & Current Price Chart
This article provides the stock price quote and current price chart for UFP Technologies Inc (UFPT). It is a landing page for Capital.com, suggesting that users can find real-time trading information and charts for UFPT through their platform.
UFP Technologies (NASDAQ:UFPT) Stock Rating Upgraded by Wall Street Zen
UFP Technologies (NASDAQ:UFPT) has received upgraded stock ratings from "sell" to "hold" by Wall Street Zen and "strong sell" to "hold" by Zacks Research, leading to a consensus "Hold" rating with an average target price of $289.00. The company reported strong Q4 earnings of $2.44 EPS, surpassing analyst expectations, and a slight revenue increase year-over-year. Despite institutional investment interest, the stock is currently trading below its average analyst target.
Vanguard disaggregates holdings; UFP Technologies (UFPT) shows 0 shares reported
Vanguard has reported zero beneficial ownership of UFP Technologies (UFPT) common stock following an internal realignment. This change is due to Vanguard disaggregating certain subsidiaries and business divisions, which will now report their holdings separately in reliance on SEC Release No. 34-39538. The filing explicitly states that this does not indicate any sale of UFPT shares by Vanguard, but rather a change in reporting structure.
Q4 Rundown: UFP Technologies (NASDAQ:UFPT) Vs Other Drug Development Inputs & Services Stocks
This article analyzes the Q4 performance of UFP Technologies (UFPT) against other drug development inputs & services stocks like Medpace (MEDP), Fortrea (FTRE), Azenta (AZTA), and IQVIA (IQV). The sector reported mixed Q4 results with revenues generally beating estimates but share prices declining. Key findings include Medpace's strongest revenue growth and analyst beat, while Fortrea showed the weakest performance.
Congress Asset Management Co. Increases Holdings in UFP Technologies, Inc. $UFPT
Congress Asset Management Co. has increased its stake in UFP Technologies (NASDAQ:UFPT) by 32.4% in the fourth quarter of 2025, now owning 441,122 shares valued at approximately $97.94 million. The company reported strong Q4 earnings, beating EPS estimates, and revenue growth of 3.4% year-over-year. Institutional investors hold a significant portion of the stock, and analysts maintain a consensus "Hold" rating with a $289 price target.
Technical Reactions to UFPT Trends in Macro Strategies
This article provides a technical analysis of UFPT, highlighting weak near and mid-term sentiment that could pressure a neutral long-term outlook. It details specific institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) with entry zones, targets, and stop losses. The analysis also includes multi-timeframe signal strengths, support, and resistance levels generated by AI models.
UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets Virtual Healthcare Forum
UFP Technologies, Inc. announced that its President, Mitchell Rock, and CFO, Ron Lataille, will participate in a virtual fireside chat at the KeyBanc Capital Markets Virtual Healthcare Forum on March 18, 2026, at approximately 10:30 AM ET. The company is a contract development and manufacturing organization specializing in single-use and single-patient medical devices. UFP Technologies serves as a critical link in the medical device supply chain, partnering with top manufacturers for devices used in various medical fields.
Medical device maker UFP Technologies to join KeyBanc virtual health forum
UFP Technologies (Nasdaq: UFPT) announced that its President Mitchell Rock and CFO Ron Lataille will participate in a virtual fireside chat and host 1x1 investor meetings at the KeyBanc Capital Markets Virtual Healthcare Forum on March 18, 2026. This participation is part of the company's ongoing investor outreach strategy, following record 2025 financial results and previous conference appearances. Despite strong fundamentals, the company has historically seen negative 24-hour price reactions to news events, indicating a stock-specific rather than sector-driven setup ahead of this forum.
UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets Virtual Healthcare Forum
UFP Technologies, a contract development and manufacturing organization specializing in medical devices, announced that its President, Mitchell Rock, and CFO, Ron Lataille, will participate in a virtual fireside chat at the KeyBanc Capital Markets Virtual Healthcare Forum on March 18, 2026, at 10:30 AM ET. The company is a key supplier of single-use and single-patient medical device components used in various medical applications.
UFP Technologies Inc Stock (ISIN: US9026731015) Eyes Strong Recovery After Record 2025 Results
UFP Technologies Inc. (US9026731015) announced record 2025 results, driven by strong demand in medical and aerospace sectors, yet its shares trade below analyst targets, implying significant upside potential. European investors can access this US industrial stock, known for custom-engineered foam and packaging solutions, via the Stuttgart exchange (STU:UFP). The company's focus on high-margin medical applications and resilient business model positions it for continued growth, with analysts maintaining a 'Hold' consensus and a $289 price target.
UFPT Fundamental Analysis & Valuation | Fair Value & Financial Strength | UFP TECHNOLOGIES INC (NASDAQ:UFPT)
This article provides a fundamental analysis and valuation of UFP Technologies Inc. (NASDAQ: UFPT), assigning it a fundamental rating of 6 out of 10. The company exhibits excellent profitability and strong financial health, with a correct valuation and medium growth rate, making it considerable for quality investing. Key metrics like profitability, health, growth, and valuation are detailed, and the article notes that UFPT does not currently pay dividends.
UFP Technologies (UFPT) director exercises options to acquire 2,864 common shares
UFP Technologies director Thomas Oberdorf exercised stock options to acquire 2,864 common shares of the company at an exercise price of $22.02 per share. Following this transaction, Oberdorf directly holds 12,417 shares of UFPT common stock, and the option grant is now fully exercised with no remaining derivative position from this specific grant. The filing, a Form 4, indicates a conversion of derivative securities into common stock rather than an open-market purchase or sale.
Geneva Capital Management LLC Has $31.64 Million Stock Holdings in UFP Technologies, Inc. $UFPT
Geneva Capital Management LLC significantly increased its stake in UFP Technologies (NASDAQ:UFPT) by 88.6% in Q3, now owning 158,496 shares valued at $31.64 million. Other institutional investors like Brown Capital Management LLC and Allspring Global Investments Holdings LLC also adjusted their holdings. The report details UFP Technologies' recent financial performance, including its Q4 earnings beat, and current analyst ratings which indicate a consensus "Hold" with a target price of $289.00.
Pharmacy Blister Packaging Market to Witness Stunning Growth
Coherent Market Insights has released a detailed report on the "Pharmacy Blister Packaging Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033." The report provides a comprehensive analysis of market dynamics, including competition, geographic distribution, growth potential, and key success factors. It highlights major market players, segmentation by pharmacy type, and offers critical insights for businesses, investors, and strategists.
UFP Technologies (UFPT) CFO has shares withheld to cover tax liability
UFP Technologies CFO Ronald J. Lataille had 2,677 shares of common stock withheld on March 2, 2026, to cover tax liabilities associated with stock unit awards from 2023, 2024, and 2025. Following this transaction, Lataille directly owns 15,898 shares and indirectly holds 38,940 shares. This information was disclosed in an SEC Form 4 filing.
American Century Companies Inc. Has $50.61 Million Holdings in UFP Technologies, Inc. $UFPT
American Century Companies Inc. has reduced its stake in UFP Technologies, Inc. by 22.0% in the third quarter, now holding 253,532 shares valued at approximately $50.605 million. Despite this, institutional ownership remains high at 87.28%, with other funds like First National Bank of Omaha initiating new positions. UFP Technologies recently beat EPS estimates but narrowly missed revenue forecasts, with analysts currently giving the stock a "Hold" rating and an average price target of $289.00.
Does UFP Technologies' (UFPT) Expanded Intuitive Deal Reframe Its Medical Automation Investment Narrative?
UFP Technologies (UFPT) recently extended and expanded its manufacturing supply agreement with Intuitive Surgical through 2029, coinciding with strong fourth-quarter and full-year 2025 earnings. This agreement provides increased visibility for UFPT's medical device operations and reinforces its investment narrative focused on automation and medical outsourcing, although customer concentration remains a key risk. The company projects significant revenue and earnings growth by 2028, with its fair value estimated at $329.50, representing a 62% upside.
Tax withholding trims UFP Technologies (UFPT) VP Jason Holt stake
UFP Technologies Vice President Jason Holt had 478 shares of common stock withheld on March 2, 2026, to cover tax liabilities. These liabilities stemmed from stock unit awards granted in 2023, 2024, and 2025 that vested on the same date. Following this transaction, Jason Holt directly owns 8,978 shares of UFP Technologies.
1 Reason to Sell UFPT and 1 Stock to Buy Instead
This article recommends selling UFP Technologies (UFPT) due to its limited distribution channels and smaller scale within an industry where size is crucial. Despite a reasonable P/E valuation, the company's fundamentals present too much downside risk. The author suggests looking into alternative growth stocks, particularly "the Amazon and PayPal of Latin America."
UFP Technologies, Inc. (UFPT): A Bull Case Theory
This article summarizes a bullish thesis on UFP Technologies, Inc. (UFPT), highlighting its strong position in medical device manufacturing, consistent financial performance, and potential for high growth. The company serves 26 of the top 30 global medical device manufacturers and has demonstrated impressive revenue and EPS growth, with a compelling balance sheet. The stock is considered to be in an attractive Buy Zone with a projected 16.5% total annual return.
UFPT: Exclusive materials, strategic acquisitions, and strong contracts fuel high-margin growth
UFP Technologies, Inc. (UFPT) is positioned for continued high-margin growth due to its exclusive access to materials, strategic acquisitions, and strong customer partnerships in the medical device CDMO sector. Recent contract extensions, robust financial performance, and geographical expansion are key drivers for its anticipated outperformance. This analysis is based on the company's 47th Annual Raymond James Institutional Investor Conference Audio Transcript from March 3, 2026.
UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 58.84% Potential Upside in the Medical Devices Sector
UFP Technologies, Inc. (UFPT) is highlighted within the medical devices sector, demonstrating strong operational performance with a revenue growth rate of 3.40% and a robust ROE of 17.82%. Analysts hold a predominantly positive outlook, with an average target price suggesting a potential upside of 58.84%, despite the stock trading below its recent moving averages. The company's strategic focus on innovation and diverse product offerings in high-growth sectors positions it for continued success.
UFP Technologies Updates Investor Presentation on Medical Growth Strategy
UFP Technologies (UFPT) has released an updated investor presentation highlighting its growth strategy in the high-margin medical device market. The presentation details its integration with major medical OEMs and its role in helping bring devices to market. The company also outlined potential risks and uncertainties, including customer concentration, supply chain issues, and regulatory changes in AI technologies. Spark, TipRanks' AI Analyst, rated UFPT as Outperform, noting strong financials but also risks from mixed technical indicators and labor inefficiencies.
UFPT Stock News Today | Earnings, Events & Price Alerts
This page provides news and event updates for UFP Technologies (UFPT). Recent news highlights include UFPT shares entering oversold territory, strong Q4 2025 earnings reported on Feb 25, 2026, and the announcement of CEO R. Jeffrey Bailly's retirement in 2026. Key events include an analysis of the company's 3-5 year financial targets, Q4 revenue reports, and the previous quarter's adjusted earnings per share.
UFP Technologies Updates Investor Presentation on Medical Growth Strategy
UFP Technologies (UFPT) has released updated investor materials for March 2026, highlighting its focus on high-margin manufacturing opportunities in the global medical device market. The presentation details the company's deep integration with major medical OEMs and outlines various operational, market, and technology risks. Spark, TipRanks' AI Analyst, rates UFPT as "Outperform," acknowledging its strong financial performance and strategic focus, balanced against technical indicators and operational challenges.
UFP Technologies (NASDAQ: UFPT) details MedTech strategy and margin targets
UFP Technologies has outlined its MedTech-focused contract manufacturing strategy, reporting $603 million in annual revenue, with 92% from medical technology customers. The company targets 12–18% revenue growth, 28–31% gross margin, and 17–20% adjusted operating margin over the next three to five years. This growth will be driven by organic expansion in high-growth MedTech niches, including robotic surgery and sterile barrier packaging, and strategic acquisitions designed to be accretive within the first year.
UFP Technologies updates investor presentation, lays out 3–5yr targets including 12–18% revenue growth
UFP Technologies has updated its investor presentation, emphasizing a strategic focus on MedTech, which accounts for approximately 92% of its revenue. The company has set 3-5 year financial targets including 12-18% revenue growth, 28-31% gross margin, and 17-20% adjusted operating margin. Its growth strategy involves organic expansion in high-growth MedTech segments and strategic acquisitions to capitalize on market opportunities in robotic surgery and CDMO.
UFP Technologies to Present and Host 1X1 Investor Meetings at the Raymond James 47th Annual Institutional Investors Conference
UFP Technologies, Inc. (Nasdaq: UFPT) announced that its Chairman and CEO, R. Jeffrey Bailly, and CFO, Ron Lataille, will participate in the Raymond James 47th Annual Institutional Investors Conference in Orlando, Florida. Their presentation is scheduled for March 3rd at 2:50 PM, with a live webcast available. The company specializes in single-use and single-patient medical devices and components.
UFP Technologies investigating cyberattack that impacted company data
UFP Technologies, a medical device manufacturer, reported a cyberattack in mid-February that compromised its IT network, billing, and label-making capabilities, resulting in potential data theft or destruction. While the company stated it continued operations using backups and believes the attack will not materially impact its financial condition due to insurance coverage, some product shipments may experience short-term delays. The incident was identified as a ransomware attack, and the company is currently assessing what sensitive information, including personally identifiable data, may have been affected.
UFP Technologies discloses cyberattack disrupting billing systems and exposing company data
UFP Technologies, a U.S. medical device manufacturer, reported a significant cyberattack around February 14, 2026. The incident disrupted billing systems, affected label making for deliveries, and led to the exfiltration or destruction of company data. While core operations continued due to contingency plans and backups, an investigation is ongoing to determine the full scope of compromised information, including personal data.
Montrusco Bolton Investments Inc. Decreases Position in UFP Technologies, Inc. $UFPT
Montrusco Bolton Investments Inc. reduced its stake in UFP Technologies (NASDAQ:UFPT) by 17.2% in the third quarter, selling 6,700 shares and retaining 32,159 shares valued at $6.42 million. This reduction comes despite UFP Technologies reporting record FY2025 results with strong sales and net income, though Q4 revenue growth was modest and margins declined, leading to mixed market reactions. Institutional ownership remains high at 87.28%, with analysts giving a consensus "Hold" rating and an average price target of $289.
UFP Technologies (UFPT) Earnings Growth Of 15.8% Tests Bearish Margin Concerns
UFP Technologies (UFPT) reported strong FY 2025 results with a 15.8% earnings growth, reaching US$8.87 EPS on US$602.8 million revenue, though net margins slightly softened to 11.3%. Analysts anticipate a 5.2% revenue growth and 13.1% earnings growth, driven by expected margin improvements despite slower sales growth compared to the broader US market. The stock trades at a P/E of 27.1x, below industry averages, and has a DCF fair value of US$336.46, suggesting potential upside especially if earnings growth trends continue.
UFP Technologies Data Breach Affects Key Systems: Investigation Underway
UFP Technologies, a designer and manufacturer of medical devices, experienced a cybersecurity incident on February 14, 2026, which disrupted key IT systems and resulted in the exfiltration or destruction of company data. While the company is still investigating the extent of the breach and the types of information affected, it has been disclosed to the SEC, and UFP Technologies anticipates insurance will cover a significant portion of related costs. Individuals who have interacted with the company are advised to monitor their accounts for unusual activity as the investigation proceeds.
UFP Technologies investigating cyberattack that impacted company data
UFP Technologies, a Massachusetts-based medical device manufacturer, is investigating a cyberattack that occurred in mid-February, resulting in company data being stolen or potentially destroyed. The attack affected most of its IT network, including billing and label-making capabilities, and could lead to short-term shipment delays. Despite the incident, the company does not anticipate a material impact on its financial condition and expects primary information systems to be restored soon.
UFP Technologies, Inc. (NASDAQ:UFPT) Q4 2025 Earnings Call Transcript
UFP Technologies, Inc. (UFPT) reported strong 2025 results, with total revenue reaching $602.8 million, nearly tripling since 2021, and significant growth in operating income and EPS despite labor inefficiencies at their Illinois facility. The company outlined strategic advancements including contract extensions, facility expansions in the Dominican Republic for medical submarkets, and successful acquisition integrations. Management also addressed a recent cybersecurity incident, stating it caused minimal operational disruption due to robust contingency plans and cybersecurity insurance.
UFP Technologies Reports Q4 2025 Earnings with Strong Growth and Strategic Developments
UFP Technologies announced strong Q4 2025 earnings, with full-year sales reaching $602.8 million, a 19.5% increase from 2024. The company demonstrated operational efficiency improvements despite labor inefficiencies and outlined strategic expansion plans, including new facilities in the Dominican Republic and a significant contract extension for robotic surgery capacity. Despite a slight revenue miss for Q4 and a decrease in adjusted EBITDA, the company achieved a 15.4% increase in EPS for the full year and maintained a healthy financial position with $92 million in cash from operations.
Medical device maker UFP Technologies warns of data stolen in cyberattack
UFP Technologies, a publicly traded medical device engineering and manufacturing company, recently disclosed a cybersecurity incident that compromised its IT systems and resulted in data theft. While the company believes the threat has been removed and primary systems are operational, the nature of the attack, possibly ransomware, is unclear, and the potential exfiltration of personal information is still under investigation. The incident is not expected to materially impact operations or financials at this time.
UFP Technologies (NASDAQ:UFPT) Sees Unusually-High Trading Volume on Strong Earnings
UFP Technologies (NASDAQ:UFPT) experienced unusually high trading volume following a strong earnings report where EPS of $2.44 beat consensus estimates by $0.18, and revenue was largely in line at $148.92 million. Despite the positive earnings, the stock saw a slight dip of 2.3%. Institutional ownership remains high at 87.28%, with several major firms increasing their stakes, and the company holds an average "Hold" rating from analysts with an average price target of $289.00.
Medical Device Maker UFP Technologies Hit by Cyberattack
UFP Technologies, a medical device manufacturer, reported a cyberattack on February 14, 2026, which involved data theft and disruption of IT systems, including billing and customer delivery labels. The company, based in Massachusetts, stated that while files were exfiltrated, their operations have continued without material impact due to contingency plans and insurance coverage. The incident appears to be a ransomware attack, but no group has yet claimed responsibility.
UFP Technologies (UFPT) Price Target Increased by 14.01% to 336.09
The average one-year price target for UFP Technologies (UFPT) has been raised by 14.01% to $336.09 per share, up from $294.78. This new target represents a 39.00% increase from the last reported closing price of $241.79. Institutional ownership data indicates a decrease in the number of funds holding UFPT, but an increase in average portfolio weight dedicated to the stock by those holding it.
UFP Technologies Inc. (UFPT) Stock Falls on Q4 2025 Earnings
UFP Technologies Inc. (UFPT) reported mixed Q4 2025 results, with diluted EPS exceeding estimates but revenue falling short. Following the announcement, the stock decreased by 2.32%. Insider trading activity showed 13 sales and no purchases in the past six months, while hedge fund activity indicated more institutional investors decreasing their positions than increasing them.
UFP Technologies Earnings: What To Look For From UFPT
UFP Technologies (NASDAQ:UFPT) is set to report earnings this Tuesday after market hours. The company beat revenue and EPS expectations last quarter, and the market anticipates 3.5% year-on-year revenue growth for the upcoming report. Despite some general underperformance in the drug development inputs & services segment, UFP Technologies rarely misses Wall Street's revenue estimates, and analysts have reconfirmed their estimates.
UFP Technologies Q4 2025 Earnings Preview: Growth, Estimates & Market Outlook - News and Statistics
UFP Technologies is set to release its Q4 2025 earnings, with market expectations for a 3.5% year-on-year revenue growth, a slowdown from the previous year. The company has a strong record of exceeding revenue forecasts, but its stock, along with the broader drug development inputs and services sector, has seen recent declines amidst market uncertainty. Analysts maintain a price target significantly above the current trading price despite the recent dip.
UFP Technologies to Report Fourth Quarter and Year-End 2025 Financial Results on February 24, 2026
UFP Technologies, Inc. (Nasdaq: UFPT) announced it will report its fourth quarter and year-end 2025 financial results on Tuesday, February 24, 2026, after the stock market closes. The company will host a conference call the following day, February 25, 2026, at 8:30 AM Eastern time, to discuss these results. Dial-in information for the conference call has been provided for both US/Canada toll-free and international participants.
UFP Technologies, Inc. to Report Q4 and Year-End Results on February 24, 2026, with Conference Call on February 25
UFP Technologies, Inc. announced it will release its Q4 and year-end 2025 financial results on February 24, 2026, after market close, with a follow-up conference call on February 25, 2026, at 8:30 AM Eastern Time. The company, a specialist in single-use medical devices, will provide dial-in information and a webcast for investors. The article also includes details on recent insider trading and institutional holdings for UFPT stock.
UFP Technologies to Report Fourth Quarter and Year-End 2025 Financial Results on February 24, 2026
UFP Technologies, Inc. (Nasdaq: UFPT) announced it will report its fourth quarter and year-end 2025 financial results on Tuesday, February 24th, after the stock market closes. The company will host a conference call to discuss these results on Wednesday, February 25th, at 8:30 AM Eastern Time. UFP Technologies specializes in the development and manufacturing of single-use and single-patient medical devices.
UFP Technologies (NASDAQ:UFPT) Trading Down 11.3% - What's Next?
UFP Technologies (NASDAQ:UFPT) saw its stock price drop by 11.3% to $218.0160 on Thursday, with trading volume significantly below average. Analyst sentiment for UFPT is mixed, holding a consensus "Hold" rating with an average price target of $289.00 despite recent downgrades and upgrades from different firms. The company, an industrial products manufacturer with a market cap of $1.77 billion, maintains high institutional ownership of 87.28%.
